| 產品名稱 |
CAS號 |
含量 |
在線訂購 |
| 2-Bromo-8-fluoro-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one |
283173-80-8 | ≥97 |
 |
| 8-Fluoro-1,3,4,5-tetrahydro-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one |
1408282-26-7 | ≥97 |
|
| 6-Fluoro-1H-indole-4-carboxylic acid methyl ester |
1082040-43-4 | ≥97 |
|
| N-(2-oxoethyl)phthalimide |
2913-97-5 | ≥97 |
|
| 5-Fluoro-2-methyl-3-nitrobenzoic acid methyl ester |
697739-03-0 | ≥97 |
|
| Pemigatinib 培米加替尼(INCB054828)中間體 |
1513857-77-6 |
≥99 |
|
| 2,6-difluoro-3,5-diMethoxybenzenaMine |
651734-54-2 | ≥97 |
|
| 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde |
958230-19-8 | ≥97 |
|
| 4-(ethylamino)-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde |
915403-16-6 | ≥97 |
|
| Selumetinib 司美替尼 (AZD6244)中間體 / Binimetinib 比尼替尼(MEK162)中間體 |
606143-52-6 |
≥99 |
|
| Methyl 5-aMino-4-fluoro-1-Methyl-1H-benzo[d]iMidazole-6-carboxylate |
918321-20-7 | ≥97 |
|
| Benzoic acid, 2,4,5-triamino-3-fluoro-, methyl ester |
918321-27-4 | ≥97 |
|
| methyl 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-1-methyl-1H-benzimidazole-6-carboxylate |
606144-02-9 | ≥97 |
|
| Erdafitinib厄達替尼中間體(JNJ-42756493) |
1346242-81-6 |
≥99 |
|
| 7-Bromo-2-chloroquinoxaline |
89891-65-6 | ≥97 |
|
| 7-bromo-1H-quinoxalin-2-one |
82031-32-1 | ≥97 |
|
| 7-bromo-2-(1-methyl-1H-pyrazol-4-yl)-quinoxaline |
1083325-87-4 | ≥97 |
|
| 2-(1-methylpyrazol-4-yl)-7- aminoquinoxaline |
1346245-04-2 | ≥97 |
|
| 2-(1-methylpyrazol-4-yl)-7-nitroquinoxaline |
1346245-03-1 | ≥97 |
|
| 7-NITRO-2(1H)-QUINOXALINONE |
89898-96-4 | ≥97 |
|
手機瀏覽
18337415656